These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 9016898

  • 21. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 22. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
    Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G.
    Am J Physiol; 1994 Dec; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
    [Abstract] [Full Text] [Related]

  • 23. Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.
    Yatsu T, Sanagi M, Fujimori A, Tomura Y, Hayashi K, Tanahashi M, Inagaki O.
    Pharmacol Res; 2003 Mar; 47(3):243-52. PubMed ID: 12591020
    [Abstract] [Full Text] [Related]

  • 24. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [Abstract] [Full Text] [Related]

  • 25. Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.
    Smit-van Oosten A, Navis G, Stegeman CA, Joles JA, Klok PA, Kuipers F, Tiebosch AT, van Goor H.
    J Pathol; 2001 May; 194(1):122-9. PubMed ID: 11329151
    [Abstract] [Full Text] [Related]

  • 26. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
    Fan YY, Baba R, Nagai Y, Miyatake A, Hosomi N, Kimura S, Sun GP, Kohno M, Fujita M, Abe Y, Nishiyama A.
    Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease.
    Remuzzi A, Gagliardini E, Sangalli F, Bonomelli M, Piccinelli M, Benigni A, Remuzzi G.
    Kidney Int; 2006 Apr; 69(7):1124-30. PubMed ID: 16395266
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
    Bos H, Henning RH, De Boer E, Tiebosch AT, De Jong PE, De Zeeuw D, Navis G.
    Kidney Int; 2002 Feb; 61(2):473-80. PubMed ID: 11849387
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.
    Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G.
    Am J Kidney Dis; 1999 Oct; 34(4):626-32. PubMed ID: 10516341
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H.
    Am J Nephrol; 2000 Oct; 20(5):373-9. PubMed ID: 11092994
    [Abstract] [Full Text] [Related]

  • 40. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
    Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD, HOlland NEphrology STudy Group.
    BMJ; 2011 Jul 26; 343():d4366. PubMed ID: 21791491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.